+ All Categories
Transcript
Page 1: Oncologic Imaging - Stritch School of Medicine

1

Oncologic Imaging

Kenneth L. Piece, M.D.Stritch School of Medicine

GOALS OF PRESENTATION

• Familiarize participant with Pathology commonly seen in Oncology patients using CT

• Investigate other imaging modalities useful in Oncological Dx

• Discuss practical issues in radiological imaging

OVERVIEW

• Anatomy most readily displayed in CT modality

• MR to supplement• Occassionally US/ plain film/

mammography

Page 2: Oncologic Imaging - Stritch School of Medicine

2

BREAST CA

• CT shows advanced disease, mammography and MR for local

• Axillary, int mamm LN seen on CT• Post RT changes of lung, bones, soft tissue

• skin thickening, pulm fibrosis, bone sclerosis• recurrence can be local - focal mass in

axilla or chest wall

Page 3: Oncologic Imaging - Stritch School of Medicine

3

Page 4: Oncologic Imaging - Stritch School of Medicine

4

Page 5: Oncologic Imaging - Stritch School of Medicine

5

Page 6: Oncologic Imaging - Stritch School of Medicine

6

Page 7: Oncologic Imaging - Stritch School of Medicine

7

BRONCHOGENIC CA

• CT modality of choice• 60% are central- hilar mass, pneumonia• 40% are peripheral- spiculated, cavitate• Evaluate nodes for staging >1-1.5cm

significant

Page 8: Oncologic Imaging - Stritch School of Medicine

8

Page 9: Oncologic Imaging - Stritch School of Medicine

9

Page 10: Oncologic Imaging - Stritch School of Medicine

10

Page 11: Oncologic Imaging - Stritch School of Medicine

11

Page 12: Oncologic Imaging - Stritch School of Medicine

12

Page 13: Oncologic Imaging - Stritch School of Medicine

13

Page 14: Oncologic Imaging - Stritch School of Medicine

14

Page 15: Oncologic Imaging - Stritch School of Medicine

15

LYMPHOMA

• CT modality of choice• Mediastinal lymphadenopathy common• CT helpful in Hodgkin’s - determines stage

and treatment• CT good for follow-up in both• Can affect lungs less commonly

Page 16: Oncologic Imaging - Stritch School of Medicine

16

Page 17: Oncologic Imaging - Stritch School of Medicine

17

HEPATOCELLULAR CARCINOMA

• More common in Asia, Africa• Usually due to EtOH in US• Can be mass, nodular or diffuse• Non-necrotic areas enhance, necrotic areas

lower density• Can invade portal/hepatic vein

Page 18: Oncologic Imaging - Stritch School of Medicine

18

Page 19: Oncologic Imaging - Stritch School of Medicine

19

Page 20: Oncologic Imaging - Stritch School of Medicine

20

PANCREATIC CANCER

• Advanced at time of Dx• Poor prognosis• 65% in pancreatic head• Findings include mass, hypodensity, dilated

duct, biliary obstruction, local invasion of vessels

Page 21: Oncologic Imaging - Stritch School of Medicine

21

Page 22: Oncologic Imaging - Stritch School of Medicine

22

Page 23: Oncologic Imaging - Stritch School of Medicine

23

Page 24: Oncologic Imaging - Stritch School of Medicine

24

LYMPHOMA

• CT modality of choice• CT good for follow-up in both• With or without splenomegaly• Follows vessels

Page 25: Oncologic Imaging - Stritch School of Medicine

25

Page 26: Oncologic Imaging - Stritch School of Medicine

26

RENAL CELL CARCINOMA

• Common, can present as painless hematuria• CT for Dx and staging• Findings

• pre - hypo to hyperdense• post - most enhance, but less than kidney• invasion of renal v, IVC, nodes

Page 27: Oncologic Imaging - Stritch School of Medicine

27

Page 28: Oncologic Imaging - Stritch School of Medicine

28

ADRENAL GLANDS

• Adenomas• unilateral, round, low density, 2-5 cm• most not functional

• Metastases• >5 cm, higher density, bilateral• lung most common

• Carcinoma -rare

Page 29: Oncologic Imaging - Stritch School of Medicine

29

PROSTATE CARCINOMA

• CT planning very useful for better targeting• CT predicts local extent 65%, 70% for

lymph nodes• Prostate usually enlarged, but can be NL• Can invade bladder base,seminal vesicles,

rectum

Page 30: Oncologic Imaging - Stritch School of Medicine

30

Page 31: Oncologic Imaging - Stritch School of Medicine

31

CERVICAL CARCINOMA

• Most common gyne ca in world• 5 yr survival rate 71%, 10% for distant

spread• Findings

• soft tissue mass lower uterus• nodes• local invasion

Page 32: Oncologic Imaging - Stritch School of Medicine

32

BONE DISEASE

• Useful for evaluation of mets in prostate CA• Pathologic fracture

• metastatic disease destroys bone, non-traumatic fx

• dx’d on plain films, but CT and MR helpful• Primary bone tumors in the pelvis

Page 33: Oncologic Imaging - Stritch School of Medicine

33

Page 34: Oncologic Imaging - Stritch School of Medicine

34


Top Related